These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 9928572)
1. New developments in high-dose chemotherapy for breast cancer. Basser RL Recent Results Cancer Res; 1998; 152():355-67. PubMed ID: 9928572 [TBL] [Abstract][Full Text] [Related]
2. Evolving concepts in the systemic drug therapy of breast cancer. Norton L Semin Oncol; 1997 Aug; 24(4 Suppl 10):S10-3-S10-10. PubMed ID: 9275000 [TBL] [Abstract][Full Text] [Related]
3. Multicycle high-dose chemotherapy and filgrastim-mobilized peripheral-blood progenitor cells in women with high-risk stage II or III breast cancer: five-year follow-up. Basser RL; To LB; Collins JP; Begley CG; Keefe D; Cebon J; Bashford J; Durrant S; Szer J; Kotasek D; Juttner CA; Russell I; Maher DW; Olver I; Sheridan WP; Fox RM; Green MD J Clin Oncol; 1999 Jan; 17(1):82-92. PubMed ID: 10458221 [TBL] [Abstract][Full Text] [Related]
4. [Studies with high-dose chemotherapy and subsequent autologous stem cell transplantation in breast carcinoma]. Nitz U; Adomeit A; Mohrmann S; Fossari A; Frick M Praxis (Bern 1994); 1998 Apr; 87(17):578-83. PubMed ID: 9623324 [TBL] [Abstract][Full Text] [Related]
5. High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer. Farquhar C; Basser R; Marjoribanks J; Lethaby A Cochrane Database Syst Rev; 2003; (1):CD003139. PubMed ID: 12535457 [TBL] [Abstract][Full Text] [Related]
6. High-dose chemotherapy and peripheral blood progenitor cell transplantation in the treatment of breast cancer. Peters WP; Dansey RD; Klein JL; Baynes RD Oncologist; 2000; 5(1):1-13. PubMed ID: 10706643 [TBL] [Abstract][Full Text] [Related]
7. Randomized trials of high dose chemotherapy for breast cancer. Antman KH Biochim Biophys Acta; 2001 Mar; 1471(3):M89-98. PubMed ID: 11250065 [TBL] [Abstract][Full Text] [Related]
8. Effect of Tailored Dose-Dense Chemotherapy vs Standard 3-Weekly Adjuvant Chemotherapy on Recurrence-Free Survival Among Women With High-Risk Early Breast Cancer: A Randomized Clinical Trial. Foukakis T; von Minckwitz G; Bengtsson NO; Brandberg Y; Wallberg B; Fornander T; Mlineritsch B; Schmatloch S; Singer CF; Steger G; Egle D; Karlsson E; Carlsson L; Loibl S; Untch M; Hellström M; Johansson H; Anderson H; Malmström P; Gnant M; Greil R; Möbus V; Bergh J; JAMA; 2016 Nov; 316(18):1888-1896. PubMed ID: 27825007 [TBL] [Abstract][Full Text] [Related]
9. High-dose chemotherapy in advanced breast cancer. Viens P; Maraninchi D Crit Rev Oncol Hematol; 2002 Feb; 41(2):141-9. PubMed ID: 11856590 [TBL] [Abstract][Full Text] [Related]
10. [High dose chemotherapy in treatment of breast carcinoma: current status and limits of this method of therapy]. Derigs HG; Huber C; Mahlke M; Kolbe K Geburtshilfe Frauenheilkd; 1996 Apr; 56(4):190-7. PubMed ID: 8682284 [TBL] [Abstract][Full Text] [Related]
11. Dose intensity and high dose therapy. Two different concepts. Livingston RB Cancer; 1994 Aug; 74(3 Suppl):1177-83. PubMed ID: 8039154 [TBL] [Abstract][Full Text] [Related]
12. High-dose chemotherapy in breast cancer. Lake DE; Hudis CA Drugs; 2004; 64(17):1851-60. PubMed ID: 15329034 [TBL] [Abstract][Full Text] [Related]
13. Overview of resistance to systemic therapy in patients with breast cancer. Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229 [TBL] [Abstract][Full Text] [Related]
14. High-dose chemotherapy with stem-cell rescue for the treatment of breast cancer. McCauley DL Am J Health Syst Pharm; 1996 Mar; 53(5):521-34; quiz 561-2. PubMed ID: 8697012 [TBL] [Abstract][Full Text] [Related]
15. A short course of induction chemotherapy followed by two cycles of high-dose chemotherapy with stem cell rescue for chemotherapy naive metastatic breast cancer. Elias AD; Richardson P; Avigan D; Ibrahim J; Joyce R; Demetri G; Levine J; Warren D; Arthur T; Reich E; Wheele C; Frei E; Ayash L Bone Marrow Transplant; 2001 Feb; 27(3):269-78. PubMed ID: 11277174 [TBL] [Abstract][Full Text] [Related]
16. High-dose chemotherapy with stem cell reinfusion and growth factor support for solid tumors. de Vries EG; de Graaf H; Boonstra A; van der Graaf WT; Mulder NH Stem Cells; 1995 Nov; 13(6):597-606. PubMed ID: 8590861 [TBL] [Abstract][Full Text] [Related]
17. Is there a standard type and duration of adjuvant chemotherapy for early stage breast cancer? Hayes DF Breast; 2009 Oct; 18 Suppl 3():S131-4. PubMed ID: 19914531 [TBL] [Abstract][Full Text] [Related]
18. Conventional adjuvant chemotherapy versus single-cycle, autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer patients: a randomized trial. Leonard RC; Lind M; Twelves C; Coleman R; van Belle S; Wilson C; Ledermann J; Kennedy I; Barrett-Lee P; Perren T; Verrill M; Cameron D; Foster E; Yellowlees A; Crown J; J Natl Cancer Inst; 2004 Jul; 96(14):1076-83. PubMed ID: 15265969 [TBL] [Abstract][Full Text] [Related]
19. High-dose chemotherapy with autologous stem cell support for breast cancer. Vahdat L; Antman K Curr Opin Hematol; 1997 Nov; 4(6):381-9. PubMed ID: 9358993 [TBL] [Abstract][Full Text] [Related]
20. Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group. Stadtmauer EA; O'Neill A; Goldstein LJ; Crilley PA; Mangan KF; Ingle JN; Brodsky I; Martino S; Lazarus HM; Erban JK; Sickles C; Glick JH N Engl J Med; 2000 Apr; 342(15):1069-76. PubMed ID: 10760307 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]